Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Biglycan Antikörper (C-Term)

Der Ziege Polyklonal anti-Biglycan Antikörper (ABIN375174) detektiert spezifisch Biglycan in WB und EIA. Dieser Antikörper reagiert spezifisch mit Proben aus Human, Ratte, Maus und Hund.
Produktnummer ABIN375174
772,31 €
Zzgl. Versandkosten 20,00 € und MwSt
0.1 mg
Lieferung nach: Deutschland
Lieferung in 16 Werktagen

Kurzübersicht für Biglycan Antikörper (C-Term) (ABIN375174)

Target

Alle Biglycan (BGN) Antikörper anzeigen
Biglycan (BGN)

Reaktivität

  • 73
  • 59
  • 54
  • 18
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Ratte, Maus, Hund

Wirt

  • 91
  • 6
  • 1
Ziege

Klonalität

  • 73
  • 25
Polyklonal

Konjugat

  • 41
  • 16
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Biglycan Antikörper ist unkonjugiert

Applikation

  • 74
  • 28
  • 25
  • 20
  • 18
  • 13
  • 13
  • 12
  • 8
  • 4
  • 3
  • 3
  • 2
  • 2
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Bindungsspezifität

    • 16
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Sequenz

    C-DRLAIQFGNY KK

    Spezifität

    This antibody recognizes Biglycan Preproprotein.

    Kreuzreaktivität (Details)

    Species reactivity (expected):Mouse, Canine.
    Species reactivity (tested):Human, Rat.

    Aufreinigung

    Ammonium Sulphate Precipitation followed by Antigen Affinity Chromatography using the immunizing peptide

    Immunogen

    Synthetic peptide from the C-Terminus of Human Biglycan (NP_001702.1) Genename: BGN
  • Applikationshinweise

    Peptide ELISA: 1/8000. Western Blot: 0.1 - 0.3 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.5 mg/mL

    Buffer

    Tris saline, pH ~7.3, 0.02 % Sodium Azide, 0.5 % BSA

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target

    Biglycan (BGN)

    Andere Bezeichnung

    Biglycan

    Hintergrund

    Biglycan is an extracellular matrix proteoglycan that is closely related in structure to decorin and fibromodulin. Biglycan and decorin are thought to be the result of a gene duplication. Biglycan is expressed in secondary myotubes during fetal muscle formation. In adult muscle it is located in the endomysium and neuromuscular junctions, where it connects to the dystrophin-associated proteins through binding to a-dystroglycan. In developing newborn mice biglycan expression is initially high and then decreases during skeletal muscle differentiation and maturation. Biglycan may also have a role in the fibrotic process since it is overexpressed in atherosclerotic lesions and has been shown to cause an increase in thymidine incorporation and migration of vascular smooth muscle cells.Synonyms: BGN, Bone/cartilage proteoglycan I, PG-S1, PGS1, SLRR1A, Small Leucine-rich Protein 1A

    Molekulargewicht

    41.7 kDa (Human NP_001702.1 and Rat NP_058783.1)

    Gen-ID

    633

    NCBI Accession

    NP_001702

    UniProt

    P21810

    Pathways

    Glycosaminoglycan Metabolic Process
Sie sind hier:
Chat with us!